Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Contactin-2/TAG-1-directed autoimmunity is identified in multiple sclerosis patients and mediates gray matter pathology in animals.

Derfuss T, Parikh K, Velhin S, Braun M, Mathey E, Krumbholz M, Kümpfel T, Moldenhauer A, Rader C, Sonderegger P, Pöllmann W, Tiefenthaller C, Bauer J, Lassmann H, Wekerle H, Karagogeos D, Hohlfeld R, Linington C, Meinl E.

Proc Natl Acad Sci U S A. 2009 May 19;106(20):8302-7. doi: 10.1073/pnas.0901496106. Epub 2009 Apr 28.

2.

Gray-matter injury in multiple sclerosis.

Rudick RA, Trapp BD.

N Engl J Med. 2009 Oct 8;361(15):1505-6. doi: 10.1056/NEJMcibr0905482. No abstract available.

PMID:
19812410
3.

The gray aspects of white matter disease in multiple sclerosis.

Steinman L.

Proc Natl Acad Sci U S A. 2009 May 19;106(20):8083-4. doi: 10.1073/pnas.0903377106. Epub 2009 May 18. Review. No abstract available.

4.

Axonal loss and gray matter pathology as a direct result of autoimmunity to neurofilaments.

Huizinga R, Gerritsen W, Heijmans N, Amor S.

Neurobiol Dis. 2008 Dec;32(3):461-70. doi: 10.1016/j.nbd.2008.08.009. Epub 2008 Sep 4.

PMID:
18804534
5.

Untapped targets in multiple sclerosis.

Meinl E.

J Neurol Sci. 2011 Dec;311 Suppl 1:S12-5.

PMID:
22206760
6.

The role of myelin oligodendrocyte glycoprotein in autoimmune demyelination: a target for multiple sclerosis therapy?

Lee DH, Linker RA.

Expert Opin Ther Targets. 2012 May;16(5):451-62. doi: 10.1517/14728222.2012.677438. Epub 2012 Apr 12. Review.

PMID:
22494461
7.

Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis.

Bernard CC, Johns TG, Slavin A, Ichikawa M, Ewing C, Liu J, Bettadapura J.

J Mol Med (Berl). 1997 Feb;75(2):77-88. Review.

PMID:
9083925
8.

High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis.

Schmierer K, Parkes HG, So PW, An SF, Brandner S, Ordidge RJ, Yousry TA, Miller DH.

Brain. 2010 Mar;133(Pt 3):858-67. doi: 10.1093/brain/awp335. Epub 2010 Jan 31.

PMID:
20123726
9.

T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis.

Iglesias A, Bauer J, Litzenburger T, Schubart A, Linington C.

Glia. 2001 Nov;36(2):220-34. Review.

PMID:
11596130
10.

Contactin-2/TAG-1, active on the front line for three decades.

Masuda T.

Cell Adh Migr. 2017 Sep 3;11(5-6):524-531. doi: 10.1080/19336918.2016.1269998. Epub 2017 Jan 31.

11.

Neurofascin as a novel target for autoantibody-mediated axonal injury.

Mathey EK, Derfuss T, Storch MK, Williams KR, Hales K, Woolley DR, Al-Hayani A, Davies SN, Rasband MN, Olsson T, Moldenhauer A, Velhin S, Hohlfeld R, Meinl E, Linington C.

J Exp Med. 2007 Oct 1;204(10):2363-72. Epub 2007 Sep 10.

12.

Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.

Rostami A, Ciric B.

J Neurol Sci. 2013 Oct 15;333(1-2):76-87. doi: 10.1016/j.jns.2013.03.002. Epub 2013 Apr 8. Review.

13.

Humoral autoimmunity in multiple sclerosis.

Meinl E, Derfuss T, Krumbholz M, Pröbstel AK, Hohlfeld R.

J Neurol Sci. 2011 Jul 15;306(1-2):180-2. doi: 10.1016/j.jns.2010.08.009. Epub 2010 Sep 3. Review.

PMID:
20817206
14.

Different mechanisms of inflammation induced in virus and autoimmune-mediated models of multiple sclerosis in C57BL6 mice.

Kishore A, Kanaujia A, Nag S, Rostami AM, Kenyon LC, Shindler KS, Das Sarma J.

Biomed Res Int. 2013;2013:589048. doi: 10.1155/2013/589048. Epub 2013 Aug 28.

15.

Th Cell Diversity in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.

Carbajal KS, Mironova Y, Ulrich-Lewis JT, Kulkarni D, Grifka-Walk HM, Huber AK, Shrager P, Giger RJ, Segal BM.

J Immunol. 2015 Sep 15;195(6):2552-9. doi: 10.4049/jimmunol.1501097. Epub 2015 Aug 3.

16.

Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination.

Berer K, Mues M, Koutrolos M, Rasbi ZA, Boziki M, Johner C, Wekerle H, Krishnamoorthy G.

Nature. 2011 Oct 26;479(7374):538-41. doi: 10.1038/nature10554.

PMID:
22031325
17.

Myelin proteolipid protein: an effective autoantigen and target of autoimmunity in multiple sclerosis.

Greer JM, Pender MP.

J Autoimmun. 2008 Nov;31(3):281-7. doi: 10.1016/j.jaut.2008.04.018. Epub 2008 May 27. Review.

PMID:
18502611
18.

Autoantigens and autoantibodies in multiple sclerosis.

Mirshafiey A, Kianiaslani M.

Iran J Allergy Asthma Immunol. 2013 Aug 28;12(4):292-303. Review.

19.

A new focal EAE model of cortical demyelination: multiple sclerosis-like lesions with rapid resolution of inflammation and extensive remyelination.

Merkler D, Ernsting T, Kerschensteiner M, Brück W, Stadelmann C.

Brain. 2006 Aug;129(Pt 8):1972-83. Epub 2006 May 19.

PMID:
16714315
20.

Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100 beta molecule, a calcium binding protein of astroglia.

Kojima K, Berger T, Lassmann H, Hinze-Selch D, Zhang Y, Gehrmann J, Reske K, Wekerle H, Linington C.

J Exp Med. 1994 Sep 1;180(3):817-29.

Supplemental Content

Support Center